A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample.


Journal

Epidemiology and psychiatric sciences
ISSN: 2045-7979
Titre abrégé: Epidemiol Psychiatr Sci
Pays: England
ID NLM: 101561091

Informations de publication

Date de publication:
15 05 2019
Historique:
pubmed: 16 5 2019
medline: 20 5 2020
entrez: 16 5 2019
Statut: epublish

Résumé

Few personalised medicine investigations have been conducted for mental health. We aimed to generate and validate a risk tool that predicts adult attention-deficit/hyperactivity disorder (ADHD). Using logistic regression models, we generated a risk tool in a representative population cohort (ALSPAC - UK, 5113 participants, followed from birth to age 17) using childhood clinical and sociodemographic data with internal validation. Predictors included sex, socioeconomic status, single-parent family, ADHD symptoms, comorbid disruptive disorders, childhood maltreatment, ADHD symptoms, depressive symptoms, mother's depression and intelligence quotient. The outcome was defined as a categorical diagnosis of ADHD in young adulthood without requiring age at onset criteria. We also tested Machine Learning approaches for developing the risk models: Random Forest, Stochastic Gradient Boosting and Artificial Neural Network. The risk tool was externally validated in the E-Risk cohort (UK, 2040 participants, birth to age 18), the 1993 Pelotas Birth Cohort (Brazil, 3911 participants, birth to age 18) and the MTA clinical sample (USA, 476 children with ADHD and 241 controls followed for 16 years from a minimum of 8 and a maximum of 26 years old). The overall prevalence of adult ADHD ranged from 8.1 to 12% in the population-based samples, and was 28.6% in the clinical sample. The internal performance of the model in the generating sample was good, with an area under the curve (AUC) for predicting adult ADHD of 0.82 (95% confidence interval (CI) 0.79-0.83). Calibration plots showed good agreement between predicted and observed event frequencies from 0 to 60% probability. In the UK birth cohort test sample, the AUC was 0.75 (95% CI 0.71-0.78). In the Brazilian birth cohort test sample, the AUC was significantly lower -0.57 (95% CI 0.54-0.60). In the clinical trial test sample, the AUC was 0.76 (95% CI 0.73-0.80). The risk model did not predict adult anxiety or major depressive disorder. Machine Learning approaches did not outperform logistic regression models. An open-source and free risk calculator was generated for clinical use and is available online at https://ufrgs.br/prodah/adhd-calculator/. The risk tool based on childhood characteristics specifically predicts adult ADHD in European and North-American population-based and clinical samples with comparable discrimination to commonly used clinical tools in internal medicine and higher than most previous attempts for mental and neurological disorders. However, its use in middle-income settings requires caution.

Identifiants

pubmed: 31088588
pii: S2045796019000283
doi: 10.1017/S2045796019000283
pmc: PMC8061253
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e37

Subventions

Organisme : Medical Research Council
ID : MR/P005918/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1002190
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012964/1
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Am J Psychiatry. 2015 Oct;172(10):967-77
pubmed: 25998281
Arch Gen Psychiatry. 2006 May;63(5):540-9
pubmed: 16651511
J Child Psychol Psychiatry. 2019 May;60(5):533-544
pubmed: 30329156
Nat Genet. 2013 Sep;45(9):984-94
pubmed: 23933821
J Child Psychol Psychiatry. 2018 Oct;59(10):1105-1113
pubmed: 29683192
Prog Cardiovasc Dis. 2010 Jul-Aug;53(1):68-78
pubmed: 20620429
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
J Child Psychol Psychiatry. 2017 Jun;58(6):655-662
pubmed: 27642116
Lancet. 2015 May 30;385(9983):2190-6
pubmed: 25726514
JAMA Psychiatry. 2017 Aug 1;74(8):841-847
pubmed: 28678992
Int J Epidemiol. 2014 Aug;43(4):1082-8
pubmed: 24729426
JAMA. 2016 May 3;315(17):1854-63
pubmed: 27139058
J Child Psychol Psychiatry. 2002 Sep;43(6):727-42
pubmed: 12236608
Curr Psychiatry Rep. 2016 Dec;18(12):111
pubmed: 27783340
Circulation. 2000 Oct 24;102(17):2031-7
pubmed: 11044416
Curr Psychiatry Rep. 2017 Nov 13;19(12):106
pubmed: 29130145
Am J Psychiatry. 2018 Feb 1;175(2):140-149
pubmed: 29050505
JAMA Psychiatry. 2016 Jul 1;73(7):705-12
pubmed: 27192050
J Consult Clin Psychol. 2012 Dec;80(6):1052-1061
pubmed: 22774792
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
JAMA Psychiatry. 2015 Nov;72(11):1110-8
pubmed: 26421861
Arch Gen Psychiatry. 2011 Jun;68(6):600-8
pubmed: 21646577
Arch Gen Psychiatry. 1999 Dec;56(12):1073-86
pubmed: 10591283
JAMA Psychiatry. 2014 Mar;71(3):319-25
pubmed: 24477798
PLoS One. 2014 Jan 23;9(1):e86141
pubmed: 24465922
Lancet Neurol. 2006 Sep;5(9):735-41
pubmed: 16914401
JAMA Psychiatry. 2017 May 1;74(5):493-500
pubmed: 28355424
Br J Psychiatry. 2013 Jul;203(1):24-34
pubmed: 23661765
Ann Intern Med. 2015 May 19;162(10):735-6
pubmed: 25984857
Lancet Psychiatry. 2016 Jun;3(6):568-78
pubmed: 27183901
Nat Rev Dis Primers. 2015 Aug 06;1:15020
pubmed: 27189265
JAMA Psychiatry. 2016 Jul 1;73(7):713-20
pubmed: 27192174
BMJ Open. 2015 May 19;5(5):e007324
pubmed: 25991451
Eur Child Adolesc Psychiatry. 2016 Nov;25(11):1151-1159
pubmed: 27021056
BMC Psychiatry. 2015 Nov 17;15:290
pubmed: 26578326

Auteurs

A Caye (A)

Department of Psychiatry, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil.

J Agnew-Blais (J)

MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.

L Arseneault (L)

MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.

H Gonçalves (H)

Post-Graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.

C Kieling (C)

Department of Psychiatry, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil.

K Langley (K)

Division of Psychological Medicine and Clinical Neurosciences; MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
School of Psychology, Cardiff University, Cardiff, UK.

A M B Menezes (AMB)

Post-Graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.

T E Moffitt (TE)

Department of Psychology and Neuroscience, Duke University, Durham, North Carolina, USA.

I C Passos (IC)

Graduation Program in Psychiatry and Laboratory of Molecular Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.

T B Rocha (TB)

Department of Psychiatry, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil.

M H Sibley (MH)

Department of Psychiatry and Behavioral Health at the Florida International University, Herbert Wertheim College of Medicine, US.

J M Swanson (JM)

Department of Pediatrics, University of California, Irvine, USA.

A Thapar (A)

School of Psychology, Cardiff University, Cardiff, UK.

F Wehrmeister (F)

Post-Graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.

L A Rohde (LA)

Department of Psychiatry, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil.
National Institute of Developmental Psychiatry for Children and Adolescents, São Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH